Floatz logo

AMLODIPINE

Iron Overload

Kevin H.M. Kuo, MD, MSc, FRCPCSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Iron Overload cohort.

Asset / SponsorPhaseRating
Deferasirox
Kevin H.M. Kuo, MD, MSc, FRCPC
Phase 4BBB
DESFERRIOXAMINE B
Beni-Suef University
Phase 4BBB
Deferiprone
Chiesi Canada Corp
Phase 4BBB
Nigella Sativa Oil
Beni-Suef University
Phase 2/3B
Hydroxyurea
Beni-Suef University
Phase 2/3B

View all 11 →

Same molecule, other indications

AMLODIPINE is also rated in:

hypertensive disorderDormant
BBB
Indicative ·
76 / 100
View asset →
essential hypertensionDormant
BBB
Indicative ·
76 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →